GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ludwig Enterprises Inc (OTCPK:LUDG) » Definitions » Retained Earnings

Ludwig Enterprises (Ludwig Enterprises) Retained Earnings : $-5.85 Mil (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Ludwig Enterprises Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Ludwig Enterprises's retained earnings for the quarter that ended in Mar. 2024 was $-5.85 Mil.

Ludwig Enterprises's quarterly retained earnings declined from Sep. 2023 ($-3.79 Mil) to Dec. 2023 ($-4.24 Mil) and declined from Dec. 2023 ($-4.24 Mil) to Mar. 2024 ($-5.85 Mil).

Ludwig Enterprises's annual retained earnings increased from . 20 ($0.00 Mil) to Dec. 2022 ($-1.79 Mil) but then declined from Dec. 2022 ($-1.79 Mil) to Dec. 2023 ($-4.24 Mil).


Ludwig Enterprises Retained Earnings Historical Data

The historical data trend for Ludwig Enterprises's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ludwig Enterprises Retained Earnings Chart

Ludwig Enterprises Annual Data
Trend Dec22 Dec23
Retained Earnings
-1.79 -4.24

Ludwig Enterprises Quarterly Data
Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Retained Earnings Get a 7-Day Free Trial -1.79 - -3.79 -4.24 -5.85

Ludwig Enterprises Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Ludwig Enterprises  (OTCPK:LUDG) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Ludwig Enterprises (Ludwig Enterprises) Business Description

Traded in Other Exchanges
N/A
Address
1749 VICTORIAN AVENUE, Suite C-350, Sparks, NV, USA, 89431
Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.